PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human Angiopoietin-2 (carrier-free), 25 μg
Recombinant Human APCS (PTX2) (carrier-free), 10 µg
Recombinant Human APCS (PTX2) (carrier-free), 100 µg
Recombinant Human APCS (PTX2) (carrier-free), 25 µg
Recombinant Human APRIL (TNFSF13) (ELISA Std.), 4 pack
Recombinant Human Arginase I (carrier-free), 10 μg
Recombinant Human Arginase I (carrier-free), 100 μg
Recombinant Human Arginase I (carrier-free), 25 μg
Recombinant Human Arginase I (carrier-free), 500 μg
Recombinant Human Asprosin (carrier-free), 10 µg
Recombinant Human Asprosin (carrier-free), 25 µg
Recombinant Human B7-H1 (PD-L1, CD274)-Fc Chimera (carrier-free), 100 µg
Recombinant Human B7-H1 (PD-L1, CD274)-Fc Chimera (carrier-free), 20 µg
Recombinant Human B7-H2-Fc Chimera (carrier-free), 10 μg
Recombinant Human B7-H2-Fc Chimera (carrier-free), 100 μg
Recombinant Human B7-H2-Fc Chimera (carrier-free), 25 μg